Proposed legislation aims to better protect data ‘supply chains’ to essential public services
Large gifts aim to boost diversity and career options amid rising costs for training doctors
Sergey Brin’s non-profit funds research into using hallucinogen for mental health treatment
The next generation of drugs vying for a slice of the potential $150bn obesity market
Shares are down 70% for the world’s largest maker of insulin pen needles and syringes since it was spun off
After a peak pandemic surge, interest in the sector has dried up
Swiss drugmaker says it will only sell medication privately if health systems cannot pay
Treatment based on science that helps axolotl salamanders restore lost limbs is now in human trials
There is concern that medications used widely for weight loss have not been tested for use by pregnant women
Federal authorities are proposing to reclassify marijuana as a less dangerous drug
Use of Car-T for lupus could drive surge in demand for a treatment that was first approved for blood cancers
Lessons from other countries highlight importance of political consensus to fix chronic funding shortfall
Pharma group seeks to catch up with rivals Eli Lilly and Novo Nordisk in sector projected to be worth $130bn a year
Health services in comparable countries have recovered faster than England, study finds
US-listed pharmacy group’s problems have been exacerbated by its struggle to move into healthcare
Incubator Flagship Pioneering plans to finance and launch array of companies using AI for pharmaceutical development
Review could be used to build support for health secretary’s reform plans
Spanish medicine maker was rocked earlier this year by allegations of fraud
Decision to associate charity with a cure turned it into Europe’s biggest funder of dementia research
Poor west African nation struggles with surge in use of toxic ‘kush’
Ageing is a long-term trend that investors can bank on
UK pharma body criticises maker of Ozempic and Wegovy over failure to report £7.8mn in transfers of value
A spinout of the medtech’s orthopaedics business would unlock value while shifting to the US could also deliver gains
Shares in London-listed maker of medical devices jump as holdings disclosed
New compound increases strength of antidote for fentanyl and other lethal drugs